Modulation of Gut Microbiota Through Dietary Intervention in Neuroinflammation and Alzheimer's and Parkinson's Diseases

被引:6
|
作者
Ayten, Serife [1 ]
Bilici, Saniye [1 ]
机构
[1] Gazi Univ, Dept Nutr & Dietet, Ankara, Turkiye
关键词
Dietary intervention; Gut microbiota; Neurodegenerative diseases; Neuroinflammation; BETA-HYDROXYBUTYRATE; SYMPTOMS; MODEL;
D O I
10.1007/s13668-024-00539-7
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Purpose of Review The gut microbiota plays a crucial role in the pathogenesis of neuroinflammation and Alzheimer's and Parkinson's diseases. One of the main modulators of the gut microbiota is the diet, which directly influences host homeostasis and biological processes. Some dietary patterns can affect neurodegenerative diseases' progression through gut microbiota composition, gut permeability, and the synthesis and secretion of microbial-derived neurotrophic factors and neurotransmitters. This comprehensive review critically assesses existing studies investigating the impact of dietary interventions on the modulation of the microbiota in relation to neurodegenerative diseases and neuroinflammation.Recent Findings There are limited studies on the effects of specific diets, such as the ketogenic diet, Mediterranean diet, vegetarian diet, and Western diet, on the progression of neuroinflammation and Alzheimer's and Parkinson's diseases through the gut-brain axis. The ketogenic diet displays promising potential in ameliorating the clinical trajectory of mild cognitive impairment and Alzheimer's disease. However, conflicting outcomes were observed among various studies, highlighting the need to consider diverse types of ketogenic diets and their respective effects on clinical outcomes and gut microbiota composition. Vegetarian and Mediterranean diets, known for their anti-inflammatory properties, can be effective against Parkinson's disease, which is related to inflammation in the gut environment. On the other hand, the westernization of dietary patterns was associated with reduced gut microbial diversity and metabolites, which ultimately contributed to the development of neuroinflammation and cognitive impairment.Summary Various studies examining the impact of dietary interventions on the gut-brain axis with regard to neuroinflammation and Alzheimer's and Parkinson's diseases are thoroughly reviewed in this article. A strong mechanistic explanation is required to fully understand the complex interactions between various dietary patterns, gut microbiota, and microbial metabolites and the effects these interactions have on cognitive function and the progression of these diseases.
引用
收藏
页码:82 / 96
页数:15
相关论文
共 50 条
  • [31] Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy
    Nohesara, Shabnam
    Abdolmaleky, Hamid Mostafavi
    Thiagalingam, Sam
    Zhou, Jin-Rong
    EPIGENOMICS, 2024, 16 (01) : 57 - 77
  • [32] Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer's Disease
    Zhu, Guangsu
    Zhao, Jianxin
    Zhang, Hao
    Wang, Gang
    Chen, Wei
    ADVANCES IN NUTRITION, 2023, 14 (04) : 819 - 839
  • [33] Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies
    Shabbir, Umair
    Arshad, Muhammad Sajid
    Sameen, Aysha
    Oh, Deog-Hwan
    NUTRIENTS, 2021, 13 (02) : 1 - 23
  • [34] Therapeutic Intervention at Cellular Quality Control Systems in Alzheimer's and Parkinson's Diseases
    Arduino, Daniela M.
    Raquel Esteves, A.
    Silva, Diana F. F.
    Martins-Branco, Diogo
    Santos, Daniel
    Gomes Pimentel, Diana F.
    Cardoso, Sandra M.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (31) : 3446 - 3459
  • [35] The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases
    Czarnik, Witold
    Fularski, Piotr
    Gajewska, Agata
    Jakubowska, Paulina
    Uszok, Zofia
    Mlynarska, Ewelina
    Rysz, Jacek
    Franczyk, Beata
    NUTRIENTS, 2024, 16 (02)
  • [36] Therapeutic modulation of neuroinflammation in Alzheimer's disease
    Heckmann, Bradlee
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 87 - 88
  • [37] Metals in Alzheimer's and Parkinson's diseases
    Barnham, Kevin J.
    Bush, Ashley I.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) : 222 - 228
  • [38] Pharmacogenomics of Alzheimer's and Parkinson's diseases
    Cacabelos, Ramon
    NEUROSCIENCE LETTERS, 2020, 726
  • [39] The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings
    Yang, Jianshe
    Liang, Junyi
    Hu, Niyuan
    He, Ningjuan
    Liu, Bin
    Liu, Guoliang
    Qin, Ying
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (10)
  • [40] Cholesterol in Parkinson's and Alzheimer's diseases
    Mirnics, Zeljka K.
    Yan, Chaohua
    Schor, Nina F.
    ANNALS OF NEUROLOGY, 2006, 60 : S54 - S55